Cargando…

Computed tomography-measured body composition and survival in rectal cancer patients: a Swedish cohort study

BACKGROUND: The association between body composition and survival in rectal cancer patients is still unclear. Therefore, we aimed to evaluate the impact of computed tomography (CT)-measured body composition on survival in rectal cancer patients, stratifying our analyses by sex, tumour location, tumo...

Descripción completa

Detalles Bibliográficos
Autores principales: Kotti, Angeliki, Holmqvist, Annica, Woisetschläger, Mischa, Sun, Xiao-Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686115/
https://www.ncbi.nlm.nih.gov/pubmed/36419131
http://dx.doi.org/10.1186/s40170-022-00297-6
_version_ 1784835669492760576
author Kotti, Angeliki
Holmqvist, Annica
Woisetschläger, Mischa
Sun, Xiao-Feng
author_facet Kotti, Angeliki
Holmqvist, Annica
Woisetschläger, Mischa
Sun, Xiao-Feng
author_sort Kotti, Angeliki
collection PubMed
description BACKGROUND: The association between body composition and survival in rectal cancer patients is still unclear. Therefore, we aimed to evaluate the impact of computed tomography (CT)-measured body composition on survival in rectal cancer patients, stratifying our analyses by sex, tumour location, tumour stage and radiotherapy. METHODS: This retrospective cohort study included 173 patients with rectal adenocarcinoma. CT colonography scans at the time of diagnosis were used to assess the skeletal muscle index (SMI) and the visceral adipose tissue area (VAT). The patients were divided into a low or high SMI group and a low or high VAT group according to previously defined cutoff values. Endpoints included cancer-specific survival (CSS) and overall survival (OS). RESULTS: In all patients, low SMI was associated with worse CSS (HR, 2.63; 95% CI, 1.35–5.12; P = 0.004) and OS (HR, 3.57; 95% CI, 2.01–6.34; P < 0.001) compared to high SMI. The differences remained significant after adjusting for potential confounders (CSS: adjusted HR, 2.28; 95% CI, 1.13–4.58; P = 0.021; OS: adjusted HR, 3.17; 95% CI, 1.73–5.82; P < 0.001). Low SMI was still related to a poor prognosis after stratifying by sex, tumour location, stage and radiotherapy (P < 0.05). High VAT was associated with better CSS (HR, 0.31; 95% CI, 0.11–0.84; P = 0.022) and OS (HR, 0.40; 95% CI, 0.17–0.97; P = 0.044) compared to low VAT among men with rectal cancer ≤ 10 cm from the anal verge. High VAT was associated with worse CSS (HR, 4.15; 95% CI, 1.10–15.66; P = 0.036) in women with rectal cancer ≤ 10 cm from the anal verge. CONCLUSIONS: Low SMI was associated with worse survival. High VAT predicted better survival in men but worse survival in women. The results suggest that CT-measured body composition is a useful tool for evaluating the prognosis of rectal cancer patients and demonstrate the need to include the sex and the tumour location in the analyses. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40170-022-00297-6.
format Online
Article
Text
id pubmed-9686115
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-96861152022-11-25 Computed tomography-measured body composition and survival in rectal cancer patients: a Swedish cohort study Kotti, Angeliki Holmqvist, Annica Woisetschläger, Mischa Sun, Xiao-Feng Cancer Metab Research BACKGROUND: The association between body composition and survival in rectal cancer patients is still unclear. Therefore, we aimed to evaluate the impact of computed tomography (CT)-measured body composition on survival in rectal cancer patients, stratifying our analyses by sex, tumour location, tumour stage and radiotherapy. METHODS: This retrospective cohort study included 173 patients with rectal adenocarcinoma. CT colonography scans at the time of diagnosis were used to assess the skeletal muscle index (SMI) and the visceral adipose tissue area (VAT). The patients were divided into a low or high SMI group and a low or high VAT group according to previously defined cutoff values. Endpoints included cancer-specific survival (CSS) and overall survival (OS). RESULTS: In all patients, low SMI was associated with worse CSS (HR, 2.63; 95% CI, 1.35–5.12; P = 0.004) and OS (HR, 3.57; 95% CI, 2.01–6.34; P < 0.001) compared to high SMI. The differences remained significant after adjusting for potential confounders (CSS: adjusted HR, 2.28; 95% CI, 1.13–4.58; P = 0.021; OS: adjusted HR, 3.17; 95% CI, 1.73–5.82; P < 0.001). Low SMI was still related to a poor prognosis after stratifying by sex, tumour location, stage and radiotherapy (P < 0.05). High VAT was associated with better CSS (HR, 0.31; 95% CI, 0.11–0.84; P = 0.022) and OS (HR, 0.40; 95% CI, 0.17–0.97; P = 0.044) compared to low VAT among men with rectal cancer ≤ 10 cm from the anal verge. High VAT was associated with worse CSS (HR, 4.15; 95% CI, 1.10–15.66; P = 0.036) in women with rectal cancer ≤ 10 cm from the anal verge. CONCLUSIONS: Low SMI was associated with worse survival. High VAT predicted better survival in men but worse survival in women. The results suggest that CT-measured body composition is a useful tool for evaluating the prognosis of rectal cancer patients and demonstrate the need to include the sex and the tumour location in the analyses. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40170-022-00297-6. BioMed Central 2022-11-23 /pmc/articles/PMC9686115/ /pubmed/36419131 http://dx.doi.org/10.1186/s40170-022-00297-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Kotti, Angeliki
Holmqvist, Annica
Woisetschläger, Mischa
Sun, Xiao-Feng
Computed tomography-measured body composition and survival in rectal cancer patients: a Swedish cohort study
title Computed tomography-measured body composition and survival in rectal cancer patients: a Swedish cohort study
title_full Computed tomography-measured body composition and survival in rectal cancer patients: a Swedish cohort study
title_fullStr Computed tomography-measured body composition and survival in rectal cancer patients: a Swedish cohort study
title_full_unstemmed Computed tomography-measured body composition and survival in rectal cancer patients: a Swedish cohort study
title_short Computed tomography-measured body composition and survival in rectal cancer patients: a Swedish cohort study
title_sort computed tomography-measured body composition and survival in rectal cancer patients: a swedish cohort study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686115/
https://www.ncbi.nlm.nih.gov/pubmed/36419131
http://dx.doi.org/10.1186/s40170-022-00297-6
work_keys_str_mv AT kottiangeliki computedtomographymeasuredbodycompositionandsurvivalinrectalcancerpatientsaswedishcohortstudy
AT holmqvistannica computedtomographymeasuredbodycompositionandsurvivalinrectalcancerpatientsaswedishcohortstudy
AT woisetschlagermischa computedtomographymeasuredbodycompositionandsurvivalinrectalcancerpatientsaswedishcohortstudy
AT sunxiaofeng computedtomographymeasuredbodycompositionandsurvivalinrectalcancerpatientsaswedishcohortstudy